LYMPHOMA



Lymphoma is white blood cell cancer that starts in the lymph nodes. The patient usually presents to their doctor with painless lymphadenopathy. Lymphomas are always of the lymphoid lineage. 


The key strategy you should use when studying leukemias and lymphomas is to stick to the buzzwords. That’s because these cancers are much too complicated. The science around them is evolving rapidly. If you try to do independent research on them, you’ll fall down a very deep rabbit hole. The boards know this, and they are almost exclusively going to ask you questions with buzzwords. Specifically focus on translocations (like t(9;22)), Auer rods, Multiple Myeloma and Reed-Sternberg cells. Treatments are generally low yield, with the exception of ATRA for AML and Imatinib for CML. 


The next big picture point I’d like to make is that you should learn the layout of a lymph node. The different lymphomas will affect different parts of the nodes, and test makers like to hit you on that.